2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Updates on HPV+ Oropharynx Cancer: Can TORS and Reduced Dose Post-Operative RT Maintain High Cure Rates and Decrease Late Toxicity in Intermediate Risk Disease?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Deborah Wong
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Deborah Wong
3 views
September 29, 2020
Login to view comments.
Click here to Login
Head&Neck
